Home / Recalls / Viatris Inc / D-0127-2025

D-0127-2025 Class II Ongoing

Recalled by Viatris Inc — Canonsburg, PA

Recall Details

Product Type
Drugs
Report Date
December 18, 2024
Initiation Date
November 18, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
65,169

Product Description

Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

Reason for Recall

Superpotent Drug and Subpotent Drug: potency failures obtained

Distribution Pattern

Nationwide within the United States and Puerto Rico

Code Information

Lot #: a) 8171269, Exp. Date Feb 2025; 8179579, Exp. Date July 2025 b)3183815, Exp. Date Nov 2024; 3189147, Exp. Date Jan 2025; 3192027, Exp. Date Feb 2025; 3202894, Exp. Date Jul 2025; 3192026, Exp. Date Feb 2025; 3199781, Exp. Date Jun 2025. 3192028, exp. date Feb 2025 3202895, exp. date July 2025

Other recalls by Viatris Inc

  • D-0204-2025 Class II — Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, (December 23, 2024)
  • D-0203-2025 Class II — Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, (December 23, 2024)
  • D-0128-2025 Class II — Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0124-2025 Class II — Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0119-2025 Class II — Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0123-2025 Class II — Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0121-2025 Class II — Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0125-2025 Class II — Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0126-2025 Class II — Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0122-2025 Class II — Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)